1. Wang, Q-Y, Liu, Y-J, Hu, Y, Xia, L-L, Wu, Y-G. . Prognostic and immune roles of UROC1 in human cancers: from mechanism exploration of NAFLD and HCC to pan-cancer analysis. In European review for medical and pharmacological sciences, 28, 622-644. doi:10.26355/eurrev_202401_35059. https://pubmed.ncbi.nlm.nih.gov/38305606/
2. Glinton, Kevin E, Levy, Harvey L, Kennedy, Adam D, Pappan, Kirk L, Elsea, Sarah H. 2018. Untargeted metabolomics identifies unique though benign biochemical changes in patients with pathogenic variants in UROC1. In Molecular genetics and metabolism reports, 18, 14-18. doi:10.1016/j.ymgmr.2018.12.005. https://pubmed.ncbi.nlm.nih.gov/30619714/